Skip to main content

Non-pharmacological interventions for cardiovascular complications in patients with rheumatoid arthritis

  • Chapter
  • First Online:
  • 835 Accesses

Abstract

According to the World Health Organization (WHO), around three quarters of all cardiovascular disease (CVD) events can be prevented by improving lifestyle-related CVD risk factors. In patients with rheumatoid arthritis (RA), the relative impact of lifestyle-related risk factors on CVD outcome, including smoking, unfavorable body compositions, unhealthy diets, and physical inactivity, remain undetermined.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. WHO Library Cataloguing in Publication Data; 2009. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf. Accessed February 9, 2015.

  2. Liao KP, Solomon DH. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology. 2013;52:45-52.

    Google Scholar 

  3. Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One. 2015;10:e0117952.

    Google Scholar 

  4. Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325-331.

    Google Scholar 

  5. van Breukelen-van der Stoep DF, Zijlmans J, van Zeben D, et al. Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis. Scand J Rheumatol. 2015;44: 443-448.

    Google Scholar 

  6. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation. 1997;96:1089-1096.

    Google Scholar 

  7. Gellert C, Schottker B, Muller H, Holleczek B, Brenner H. Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults. Eur J Epidemiol. 2013;28:649-658.

    Google Scholar 

  8. Brady SR, de Courten B, Reid CM, Cicuttini FM, de Courten MP, Liew D. The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol. 2009;36: 34-40.

    Google Scholar 

  9. Serra-Bonett N, Rodriguez MA. The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis. Rheumatol Int. 2011;31:567-572.

    Google Scholar 

  10. Chung CP, Oeser A, Raggi P, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005;52:3045-3053.

    Google Scholar 

  11. Zampeli E, Protogerou A, Stamatelopoulos K, et al. Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther. 2012;14:R44.

    Google Scholar 

  12. Sliem H, Nasr G. Change of the aortic elasticity in rheumatoid arthritis: Relationship to associated cardiovascular risk factors. J Cardiovasc Dis Res. 2010;1:110-115.

    Google Scholar 

  13. Gerli R, Sherer Y, Vaudo G, et al. Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci. 2005;1051:281-290.

    Google Scholar 

  14. England BR, Sayles H, Michaud K, et al. Cause-specific mortality in US veteran men with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68:35-45.

    Google Scholar 

  15. Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum. 2008;58:2612-2621.

    Google Scholar 

  16. Zonana-Nacach A, Santana-Sahagun E, Jimenez-Balderas FJ, Camargo-Coronel A. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. J Clin Rheumatol. 2008;14:74-77.

    Google Scholar 

  17. Ikdahl E, Rollefstad S, Olsen IC, et al. EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic. BioMed Res Int. 2015;2015:515280.

    Google Scholar 

  18. Naranjo A, Khan NA, Cutolo M, et al. Smoking cessation advice by rheumatologists: results of an international survey. Rheumatology. 2014;53:1825-1829.

    Google Scholar 

  19. Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008:CD000165.

    Google Scholar 

  20. National Health Service. Smoking and rheumatoid arthritis: how to deliver brief smoking advice. http://www.nras.org.uk/data/files/For%20professionals/Smoking%20and%20RA/RA%20Smoking%20Brief%20advice%20leaflet1.pdf. Accessed February 9, 2015.

  21. Phs Guideline Update Panel L, Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008;539:1217-1222.

    Google Scholar 

  22. Gritz ER, Vidrine DJ, Fingeret MC. Smoking cessation a critical component of medical management in chronic disease populations. Am J Prev Med. 2007;33:414-422.

    Google Scholar 

  23. Aimer P, Stamp L, Stebbings S, Valentino N, Cameron V, Treharne GJ. Identifying barriers to smoking cessation in rheumatoid arthritis. Arthritis Care Res. 2015;67:607-615.

    Google Scholar 

  24. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63:2985-3023.

    Google Scholar 

  25. Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008;10:R30.

    Google Scholar 

  26. Wolfe F, Michaud K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res. 2012;64:1471-1479.

    Google Scholar 

  27. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, et al. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis. 2009;68:242-245.

    Google Scholar 

  28. Escalante A, Haas RW, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med. 2005;165:1624-1629.

    Google Scholar 

  29. Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2004;50:3450-3457.

    Google Scholar 

  30. Challal S, Minichiello E, Boissier MC, Semerano L. Cachexia and adiposity in rheumatoid arthritis. Relevance for disease management and clinical outcomes. Joint Bone Spine. 2015; doi:10.1016/j.jbspin.2015.04.010 [Epub ahead of print].

  31. Elkan AC, Hakansson N, Frostegard J, Cederholm T, Hafstrom I. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a crosssectional study. Arthritis Res Ther. 2009;11:R37.

    Google Scholar 

  32. Delgado-Frias E, Gonzalez-Gay MA, Muniz-Montes JR, et al. Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2015;33:516-523.

    Google Scholar 

  33. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis. 2007;66:1316-1321.

    Google Scholar 

  34. Uutela T, Kautiainen H, Jarvenpaa S, Salomaa S, Hakala M, Hakkinen A. Waist circumference based abdominal obesity may be helpful as a marker for unmet needs in patients with RA. Scand J Rheumatol. 2014;43:279-285.

    Google Scholar 

  35. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2960-2984.

    Google Scholar 

  36. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis. 2012;223:1-68.

    Google Scholar 

  37. Anderson TJ, Gregoire J, Hegele RA, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29:151-167.

    Google Scholar 

  38. Sempos CT, Liu K, Ernst ND. Food and nutrient exposures: what to consider when evaluating epidemiologic evidence. Am J Clin Nutr. 1999;69:1330-1338.

    Google Scholar 

  39. Hagen KB, Byfuglien MG, Falzon L, Olsen SU, Smedslund G. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev. 2009:CD006400.

    Google Scholar 

  40. McKellar G, Morrison E, McEntegart A, et al. A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Ann Rheum Dis. 2007;66:1239-1243.

    Google Scholar 

  41. Olendzki BC, Leung K, Van Buskirk S, Reed G, Zurier RB. Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids. Evid Based Complement Alternat Med. 2011;2011:827286.

    Google Scholar 

  42. Crilly MA, McNeill G. Arterial dysfunction in patients with rheumatoid arthritis and the consumption of daily fruits and daily vegetables. Eur J Clin Nutr. 2012;66:345-352.

    Google Scholar 

  43. Malik VS, Hu FB. Popular weight-loss diets: from evidence to practice. Nat Clin Pract Cardiovasc Med. 2007;4:34-41.

    Google Scholar 

  44. Sattelmair J, Pertman J, Ding EL, Kohl HW 3rd, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation. 2011;124:789-795.

    Google Scholar 

  45. Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219-229.

    Google Scholar 

  46. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116:682-692.

    Google Scholar 

  47. Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseasesmyokine regulation. Nat Rev Rheumatol. 2015;11:86-97.

    Google Scholar 

  48. Veldhuijzen van Zanten JJ, Rouse PC, Hale ED, et al. Perceived barriers, facilitators and benefits for regular physical activity and exercise in patients with rheumatoid arthritis: a review of the literature. Sports Med. 2015. 2015;45:1401-1412.

    Google Scholar 

  49. Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. The role of exercise in the management of rheumatoid arthritis. Expert Rev Clin Immunol. 2015;11:1121-1130.

    Google Scholar 

  50. Jahanbin I, Hoseini Moghadam M, Nazarinia MA, Ghodsbin F, Bagheri Z, Ashraf AR. The effect of conditioning exercise on the health status and pain in patients with rheumatoid arthritis: a randomized controlled clinical trial. Int J Community Based Nurs Midwifery. 2014;2:169-176.

    Google Scholar 

  51. Hakkinen A, Pakarinen A, Hannonen P, et al. Effects of prolonged combined strength and endurance training on physical fitness, body composition and serum hormones in women with rheumatoid arthritis and in healthy controls. Clin Exp Rheumatol. 2005;23:505-512.

    Google Scholar 

  52. Stavropoulos-Kalinoglou A, Metsios GS, Veldhuijzen van Zanten JJ, Nightingale P, Kitas GD, Koutedakis Y. Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis. 2013;72:1819-1825.

    Google Scholar 

  53. Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, et al. Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a crosssectional study. Rheumatology. 2015;54:2215-2220.

    Google Scholar 

  54. Baxter SV, Hale LA, Stebbings S, Gray AR, Smith CM, Treharne GJ. Walking is a feasible physical activity for people with rheumatoid arthritis: a feasibility randomized controlled trial. Musculoskeletal Care. 2015 [Epub ahead of print]; doi:10.1002/msc.1112.

  55. Baillet A, Zeboulon N, Gossec L, et al. Efficacy of cardiorespiratory aerobic exercise in rheumatoid arthritis: meta-analysis of randomized controlled trials. Arthritis Care Res. 2010;62:984-992.

    Google Scholar 

  56. Baillet A, Vaillant M, Guinot M, Juvin R, Gaudin P. Efficacy of resistance exercises in rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology. 2012;51:519-527.

    Google Scholar 

  57. Law RJ, Saynor ZL, Gabbitas J, et al. The effects of aerobic and resistance exercise on markers of large joint health in stable rheumatoid arthritis patients: a pilot study. Musculoskeletal care. 2015;13:222-235.

    Google Scholar 

  58. Seneca T, Hauge EM, Maribo T. Comparable effect of partly supervised and self-administered exercise programme in early rheumatoid arthritis - a randomised, controlled trial. Dan Med J. 2015;62:A5127.

    Google Scholar 

  59. Yu CA, Rouse PC, Veldhuijzen Van Zanten JJ, et al. Subjective and objective levels of physical activity and their association with cardiorespiratory fitness in rheumatoid arthritis patients. Arthritis Res Ther. 2015;17:59.

    Google Scholar 

  60. van der Goes MC, Hoes JN, Cramer MJ, et al. Identifying factors hampering physical activity in longstanding rheumatoid arthritis: what is the role of glucocorticoid therapy? Clin Exp Rheumatol. 2014;32:155-161.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ikdahl, E. (2017). Non-pharmacological interventions for cardiovascular complications in patients with rheumatoid arthritis. In: Semb, A. (eds) Handbook of Cardiovascular Disease Management in Rheumatoid Arthritis. Adis, Cham. https://doi.org/10.1007/978-3-319-26782-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26782-1_6

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-26780-7

  • Online ISBN: 978-3-319-26782-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics